Last reviewed · How we verify
NCT03571659
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
trial testing Laser in Diabetic Retinopathy in 32 participants. Completed in 11 August 2015.
22 December 2014
Quick facts
| Lead sponsor | L.V. Prasad Eye Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 32 |
| Start date | 22 December 2014 |
| Primary completion | 22 December 2014 |
| Estimated completion | 11 August 2015 |
Drugs / interventions tested
- Laser
Conditions studied
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
Sponsor
L.V. Prasad Eye Institute
Who can join
Adults 18 to 99, any sex, with Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the safety and efficacy of two subthreshold parameters (5% and 15% duty cycle (DC)) compared to standard ETDRS (early treatment of diabetic retinopathy study) continuous wave (CW) laser
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema.
Chhablani J, Alshareef R, Kim DT, Narayanan R, et al · · 2018 · cited 31× · PMID 29996798 · DOI 10.1186/s12886-018-0841-z
Verify or expand the search:
- PubMed search for NCT03571659
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Laser
Trials testing the same drug.
- NCT07247825 — Efficacy of Therapeutic Percutaneous Electrolysis vs Laser Therapy in Supraspinatus Tendinopathy. · NA · not yet recruiting
- NCT06986759 — Comparative Effects of Laser and Extracorpeal Shock Wave in Patients With Achilles Tendinopathy. · NA · not yet recruiting
- NCT06855992 — Transcutaneous Laser Therapy in Chronic Kidney Disease · NA · not yet recruiting
- NCT06643884 — Suprachoroidal Administration in Subjects With Metastases to the Choroid · Phase 2 · recruiting
- NCT07013708 — Effectiveness of Low-intensity Laser on Pain in Patients With Supraspinatus Tendinopathy · NA · completed
Other recruiting trials for Diabetic Retinopathy
Currently open trials in the same condition.
- NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes · NA · recruiting
- NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting
- NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy · NA · recruiting
Other L.V. Prasad Eye Institute trials
Trials by the same sponsor.
- NCT04843839 — CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops · Phase 2 · unknown
- NCT04618510 — SEED-LVPEI Myopia Study · NA · unknown
- NCT06613919 — Six-months Versus Nine-months ATT for Ocular TB · Phase 4 · completed
- NCT03548805 — Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma · NA · completed
- NCT03541551 — Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03571659 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by L.V. Prasad Eye Institute
- Last refreshed: 27 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03571659.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing